Groups
|
ALT(U/L)
|
AST(U/L)
|
GGT(U/L)
|
---|
Control
| 23.05 ± 1.68 | 62.47 ± 3.65 | 31.68 ± 4.38 |
NDEA
| 75.20 ± 1.52 a | 101.22 ± 2.66 a | 87.84 ± 10.45 a |
Pre S.m
| 41.43 ± 1.13 b | 82.27 ± 1.54 b | 53.02 ± 4.77 b |
Pre G.b
| 36.09 ± 1.24 b | 81.62 ± 3.05 b | 53.29 ± 7.68 b |
Post S.m
| 53.55 ± 2.48 b,c | 92.23 ± 6.24 b,c | 68.03 ± 5.36 b,c |
Post G.b
| 46.97 ± 2.09 b,d | 95.47 ± 3.71 b,d | 68.27 ± 8.39 b,d |
- Results are given as mean ± S.D. for 6 rats. Pre S.m= Pretreated silymarin, Pre G.b= Pretreated EGb, Post S.m= Posttreated silymarin, Post G.b= Posttreated EGb. a: significantly different from control group at p ≤ 0.05. b: significantly different from NDEA group at p ≤ 0.05. c: significantly different from Pre S.m group at p ≤ 0.05. d: significantly different from Pre G.b group at p ≤ 0.05.